On June 3, 2019 ImmunityBio , a privately held immunotherapy company at late stage clinical development, that aims to synergistically deploy a broad portfolio of biological molecules as an integrated cancer vaccine platform targeting multiple tumor types without the use of high-dose chemotherapy, reported that Dr. Patrick Soon-Shiong will be presenting at the Jefferies 2019 Annual Healthcare Conference being held in New York City from June 4th-7th 2019 (Press release, ImmunityBio, JUN 3, 2019, View Source [SID1234542351]). The presentation and one-on-one discussions will launch the privately held company with a portfolio of over 20 first in class biological molecules deployed to orchestrate the innate and adaptive immune system, and will feature clinical updates of multiple trials with registrational intent.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Details:

Event: Jefferies 2019 Annual Healthcare Conference

Date/Time: Tuesday, June 4, 2019, Presentation at 8:00am ET

Location: New York, NY

For more information regarding ImmunityBio please visit www.ImmunityBio.com